drugset / Trial / NCT01630187

Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section

NCT01630187

Phase 4 Completed 72 enrolled Laval University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness of two doses of carbetocin (50 mcg vs 100 mcg) in preventing uterine atony during elective cesarean section.

Timeline

Start
2012-04
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbetocin Peptide 50 ug
Comparator Carbetocin Peptide 100 ug

Indications